OTLK · CIK 0001649989 · operating
Outlook Therapeutics, Inc. (OTLK) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $32 million, Outlook Therapeutics, Inc. is a micro-cap company. The stock currently trades at $0.43, up 1.29% today, with a 52-week range of $0.38–$3.39.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.79 | $-1.79 | +55.9% | |
| 2024 | $-4.06 | $-4.06 | -1591.7% | |
| 2023 | $-0.24 | $-0.24 | +22.6% | |
| 2022 | $-0.31 | $-0.31 | +11.4% | |
| 2021 | $-0.35 | $-0.35 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | $-1.22 | $-1.22 | +32.2% | |
| 2017 | $-1.80 | $-1.67 | — | |
| 2016 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-09-30 | 2025-12-19 | 0001104659-25-123264 | SEC ↗ |
| 2024-09-30 | 2024-12-27 | 0001558370-24-016491 | SEC ↗ |
| 2023-09-30 | 2023-12-22 | 0001558370-23-020000 | SEC ↗ |
| 2022-09-30 | 2022-12-29 | 0001558370-22-019036 | SEC ↗ |
| 2021-09-30 | 2021-12-23 | 0001558370-21-017007 | SEC ↗ |
| 2020-09-30 | 2020-12-23 | 0001558370-20-014540 | SEC ↗ |
| 2019-09-30 | 2019-12-19 | 0001104659-19-074095 | SEC ↗ |
| 2018-09-30 | 2018-12-18 | 0001144204-18-065142 | SEC ↗ |
| 2017-09-30 | 2017-12-29 | 0001571049-17-008779 | SEC ↗ |
| 2016-09-30 | 2016-12-29 | 0001571049-16-020882 | SEC ↗ |